Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Live attenuated Listeria monocytogenes bioengineered with a chimeric human epidermal growth factor receptor 2 fused to a truncated form of the Lm protein listeriolysin O

EU orphan designation number: EU/3/15/1595   
Active ingredient: Live attenuated Listeria monocytogenes bioengineered with a chimeric human epidermal growth factor receptor 2 fused to a truncated form of the Lm protein listeriolysin O
Indication: Treatment of osteosarcoma
Sponsor: Coté Orphan Consulting UK Limited
c/o Elemental CoSec, 27 Old Gloucester Street, London WC1N 3AX, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2015 Orphan designation EMA/OD/162/15 (2015)9517 of 14/12/2015